Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction

Maria Grazia Franzosi1, Massimo Brunetti2, Roberto Marchioli3, Rosa Maria Marfisi3, Gianni Tognoni1, Franco Valagussa4
1Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
2Laboratory of Health Services Research, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milano, Italy
3Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro, Italy
4Cardiology Department, San Gerardo Hospital, Monza, Italy

Tóm tắt

Từ khóa


Tài liệu tham khảo

1999, Lancet, 354, 447, 10.1016/S0140-6736(99)07072-5

Gerard, 1999, Health Policy, 46, 217, 10.1016/S0168-8510(98)00061-X

Robinson, 1999, Health Policy, 49, 13, 10.1016/S0168-8510(99)00040-8

Drummond, 1991, Int J Technol Assess Health Care, 7, 561, 10.1017/S0266462300007121

Franzosi, 1998, Pharmacoeconomics, 13, 337, 10.2165/00019053-199813030-00008

Jha, 1995, Ann Intern Med, 123, 860, 10.7326/0003-4819-123-11-199512010-00009

Simopoulos, 1991, Am J Clin Nutr, 54, 438, 10.1093/ajcn/54.3.438

Simopoulos, 1997, Can J Physiol Pharmacol, 75, 234

Marchioli, 1993, G Ital Cardiol, 23, 933

Bang, 1976, Acta Med Scand, 200, 69, 10.1111/j.0954-6820.1976.tb08198.x

Burr, 1989, Lancet, ii, 757, 10.1016/S0140-6736(89)90828-3

Briggs, 1999, BMJ, 319, 120, 10.1136/bmj.319.7202.120

Briggs, 1994, Health Econ, 3, 95, 10.1002/hec.4730030206

Moriarty, 1998, Am J Cardiol, 82, 505, 10.1016/S0002-9149(98)00367-1

Pearce, 1998, Am J Hypertens, 11, 618, 10.1016/S0895-7061(97)00488-3

Marchioli, 1999, Lancet, 354, 1556, 10.1016/S0140-6736(05)76586-7

1994, Lancet, 344, 1383

Sacks, 1996, N Engl J Med, 335, 1001, 10.1056/NEJM199610033351401

1998, N Engl J Med, 339, 1349, 10.1056/NEJM199811053391902

Hill, 2000, JAMA, 283, 2116, 10.1001/jama.283.16.2116

Rennie, 2000, JAMA, 283, 2158, 10.1001/jama.283.16.2158

Schwartz, 1967, J Chronic Dis, 20, 637, 10.1016/0021-9681(67)90041-0

Mark, 1995, N Engl J Med, 332, 1418, 10.1056/NEJM199505253322106

Sheldon, 1996, Health Econ, 5, 1, 10.1002/(SICI)1099-1050(199601)5:1<1::AID-HEC183>3.0.CO;2-K

Detsky, 1990, Ann Intern Med, 113, 147, 10.7326/0003-4819-113-2-147

Naylor, 1996, ACP J Club, 124, A12, 10.7326/ACPJC-1996-124-1-A12

Van der Weijden, 1998, J Epidemiol Community Health, 52, 586, 10.1136/jech.52.9.586

Morris, 1997, J Health Serv Res Policy, 2, 231, 10.1177/135581969700200408

Hay, 1999, Pharmacoeconomics, 15, 47, 10.2165/00019053-199915010-00004

Johannesson, 1997, N Engl J Med, 336, 332, 10.1056/NEJM199701303360503

Jonsson, 1996, Eur Heart J, 17, 1001, 10.1093/oxfordjournals.eurheartj.a014994

Szucs, 1998, Herz, 23, 319, 10.1007/BF03044365